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This volume represents the proceedings of
a conference co-sponsored by the Epidemi-
ology Branch of the National Cancer In-
stitute and the National Foundation-March
of Dimes. Although the date of the con-
ference is not stated, some of the references
are as late as 1976. There are sections
dealing with relevant epidemiology, births,
defects and cancer, cytogenetics, single gene
disorders, cancer families, genetic markers,
cell hybridisation, DNA repair, theories and
future prospects.
The "cause" of common cancers is as
elusive as ever. Tumour immunology
remains extremely complex andconfusing and
the role of oncogenic viruses in man is
not yet clear. Nevertheless, there is an
impressivelistofachievementsinfundamental
cancer genetics, notably in cytogenetics, in
cell fusion studies and in progress in identi-
fying disorders of DNA repair. There are now
more than 40 rare cancers which are known to
have Mendelian inheritance (but in which
pathogenesis is often obscure) and an
increasing number of genetic markers appear
to be associated with cancer proneness or
resistance. The potential importance of
genetic marker studies is seen in ankylosing
spondylitis. If ankylosing spondylitis were a
curable cancer when diagnosed early, it
would probably be justified to HLA-B27
type all young males, since those positive
would have more than 100 times the risk of
those negative. The importance of cancer
registers is likely to increase as such genetic
markers become available. Scolnick describes
his work with the Mormons in which he is
"...trying to put together the genealogy of
the entire State of Utah ... (linked) to a
tumour registry ... so that the familial cases
can be studied in the context of other cancer
cases in the population". Total ascertainment
would largely eliminate the problem of
handling bias and if allied to genetic and
other marker studies and the computerised
recording of all known exposure to environ-
mental carcinogens, might well lead to a
clear understanding of the total accumula-
tion of cancer proneness which affects each of
us at various ages. However, there is much
discussion of and some distaste for the
concept of disease registers and many fear to
make easily available too much detailed
information about ourselves and our weak-
nesses. If reasonable confidentiality can be
guaranteed, as appears to be the case in
Utah, the next half century might well see
profitable computerisation ofmedical, genetic
and environmental data on a prospective
basis for the whole population. Events
separated in time and space affecting dif-
ferent members of the family would be put
into perspective, and the origins of common
cancers uncovered. Ultimately, the combina-
tion of computerised disease registers, genetic
markers and tests of fundamental sub-
cellular changes may greatly reduce the
cancer problem.
This volume will be of great interest to
everyone interested in cancer, since virtually
all aspects of the genetics and relevant
epidemiology are considered by a galaxy of
authors. The majority of articles are admir-
ably short with excellent bibliographies, and
this book represents a key acquisition for
libraries. Many clinicians and research
workers in the field will want a personal copy.
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The appearance of the second edition of
this book will be generally welcomed, since
being of encyclopaedic proportions, it aspires
to the status of a standard text-book,
bringing together a considerable diversity of
information between the same covers. It is
intended primarily for clinicians whose
concern is with the management ofmalignant
disease. As such it covers a wide area, from
the scientific foundations of tumour646 BOOK REVIEWS
immunology in laboratory animals, to the
clinical exploitation of immunotherapeutic
manoeuvres and the effects of other modali-
ties, particularly chemotherapy, on parame-
ters of the immune response. In addition,
there is a comprehensive chapter on immune
deficiency states associated with lymphore-
ticular malignanev.
Since the publication of the first edition
(1970) cellular immunology has seen numer-
ous advances, particularly in the classifica-
tion of subpopulations of lymphoid cells.
This has led to new insights into the classi-
fication and therapy of lymphoid neo-
plasms on the one hand, and to a greater
awareness of the potential diversity and
complexity of anti-tumour effector mech-
anisms on the other. This new information is
well represented, though the evidence that
human tumours possess specific antigens
against which the host mounts a defensive
response, remains inconclusive. It is a
concept which clinicians and scientists
alike passionately wish to believe.
The book is a valuable assemblage of
information in the effects ofcytotoxic therapy
on immune function, particularly from
recent studies of leukaemic children on long-
term remission schedules of chemotherapy.
The influence ofsteroids on adaptive and non-
specific immunity is discussed, and parti-
cular attention is given to the problem of
the infectious complications which may
ensue in patients on anti-cancer drugs,
including prophylactic measures. In addition,
the use of immunosuppressive anti-cancer
drugs, both in diseases where disordered
immune function is suspected, and in the sup-
pression of the allograft rejection reaction in
human transplantation, is discussed, and the
importance ofimmunosuppressive therapy. in
the latter context, and in the treatment of
autoimmune diseases, is evaluated.
The nonclinical sections of the text,
dealing mainly with the antigens of experi-
mental neoplasms, immunosurveillance and
the nature of anti-tumour immune responses,
are comprehensive and frequently detailed.
For the clinician, this information will prove
adequate enough, if not overwhelming. Its
relevance to the multifarious problem of
human malignancy will be less apparent,
though he will detect a distinct bias in
favour ofa viral involvement in the aetiology
of at least some human neoplasms.
There is little doubt that as a means of
investigating aspects of the fundamental bio-
logyofmalignant transformation, immunolog-
ical concepts and techniques have made a
significant contribution. In its applied aspect,
particularly in relation to immunotherapy,
the impact of the discipline has been less
clear, though there are approaches which may
yet justify the present pervasive interest in
this area.
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This book combines very successfully all
the known features of these fascinating yet
exasperating tumours of the sympathetic
nervous system.
Three chapters are devoted to the clinical
behaviour of these tumours, in different sites
and atall ages, including an important chapter
on its special behaviour in infancy. The
problems of skeletal metastases, their de-
tection and prognosis are covered well in a
separate chapter.
G. Sitlow et al. describe the changes in
catecholamine metabolism which occur in
patients with neuroblastoma, and discuss the
study of the changes in urinary excretion of
catecholamines and metabolites, both for
diagnosis and surveillance during therapy.
Two chapters cover the histogenesis, path-
ology and biology of the neuroblastoma,
including the studies on nerve growth factor,
and in Zivo and in vitro studies on the growth
of neuroblasts.
The immunological patterns of children
with neuroblastoma are described, and the
place of possible immunotherapy, and the
problems still to be solved ifthis is to be used
successfully are fully discussed, including the
warning that at present this type of therapy
may even be dangerous.
The whole span of tumours of sympathetic
nerve tissue is completed by an excellent
chapter on the benign ganglioneuroma.
There are excellent chapters on the re-
spective roles of all three modes of treatment
(namely surgery, radiotherapy and chemo-
therapy) which may be used in the manage-
ment of children with neuroblastoma. all the
contributors being aware of the considerable
shortcomings of their own mode.